Eric Topol flags a nationwide recall of a compounded GLP-1 drug, saying the tirzepatide product puts patients at risk.
Recap by typeshit. Post by Eric Topol on X.
NSW peptide hospitalisations went from five in July 2025 to over 200 in September 2026, and needle programs say syringe machines are emptying within hours.
Bikman says midface volume drops about 7% for every 10 kg lost, and that bariatric surgery patients see the same change.
A woman with bipolar disorder developed tremor and slurred speech three weeks into Zepbound. An outside expert advises checking lithium levels early, not avoiding the drugs.
8:51
Regan Archibald takes on a common question from people using retatrutide: whether the tiredness some report wears off.
A look at which peptide treatments actually carry FDA approval as interest in them grows. The full story has the details.
Doctors quoted by Men's Journal raise concerns about how much GLP-1 users are paying for add-on supplements each month.
Loading…